BlackRock Health Sciences Term Trust (NYSE:BMEZ) Major Shareholder Buys 32,055.88 in Stock

BlackRock Health Sciences Term Trust (NYSE:BMEZ) major shareholder Saba Capital Management, L.P. purchased 2,006 shares of BlackRock Health Sciences Term Trust stock in a transaction dated Monday, September 23rd. The stock was bought at an average price of 15.98 per share, with a total value of 32,055.88. Following the completion of the purchase, the insider now directly owns 20,603,574 shares of the company’s stock, valued at 329,245,112.52. The purchase was disclosed in a legal filing with the SEC, which is available through this link. Major shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.

Saba Capital Management, L.P. also recently made the following trade(s):

• On Thursday, September 19th, Saba Capital Management, L.P. bought 15,455 shares of BlackRock Health Sciences Term Trust stock. The shares were acquired at an average price of 16.14 per share, with a total value of 249,443.70.
• On Tuesday, September 17th, Saba Capital Management, L.P. bought 27,148 shares of BlackRock Health Sciences Term Trust stock. The shares were acquired at an average price of 15.93 per share, with a total value of 432,467.64.

BlackRock Health Sciences Term Trust Stock Performance

Shares of NYSE BMEZ opened at 15.72 on Thursday. The firm has a 50 day moving average of 15.84 and a 200 day moving average of 15.54. BlackRock Health Sciences Term Trust has a 12-month low of 12.93 and a 12-month high of 16.59.

BlackRock Health Sciences Term Trust Dividend Announcement

The firm also recently announced a monthly dividend, which will be paid on Thursday, October 31st. Investors of record on Tuesday, October 15th will be given a dividend of $0.176 per share. The ex-dividend date is Tuesday, October 15th. This represents a $2.11 annualized dividend and a yield of 13.43%.

Institutional Trading of BlackRock Health Sciences Term Trust

Several large investors have recently added to or reduced their stakes in the business. Pine Valley Investments Ltd Liability Co grew its position in BlackRock Health Sciences Term Trust by 6.7% during the fourth quarter. Pine Valley Investments Ltd Liability Co now owns 13,088 shares of the company’s stock valued at $192,000 after buying an additional 822 shares during the period. Dakota Wealth Management lifted its holdings in BlackRock Health Sciences Term Trust by 5.3% during the second quarter. Dakota Wealth Management now owns 18,242 shares of the company’s stock valued at $280,000 after purchasing an additional 915 shares in the last quarter. Benjamin F. Edwards & Company Inc. lifted its holdings in BlackRock Health Sciences Term Trust by 21.7% during the first quarter. Benjamin F. Edwards & Company Inc. now owns 5,830 shares of the company’s stock valued at $96,000 after purchasing an additional 1,038 shares in the last quarter. Oppenheimer & Co. Inc. lifted its holdings in BlackRock Health Sciences Term Trust by 2.0% during the fourth quarter. Oppenheimer & Co. Inc. now owns 76,699 shares of the company’s stock valued at $1,124,000 after purchasing an additional 1,536 shares in the last quarter. Finally, Kingswood Wealth Advisors LLC lifted its holdings in BlackRock Health Sciences Term Trust by 9.2% during the first quarter. Kingswood Wealth Advisors LLC now owns 21,988 shares of the company’s stock valued at $360,000 after purchasing an additional 1,845 shares in the last quarter.

About BlackRock Health Sciences Term Trust

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.